ID GBA1_PANTR Reviewed; 536 AA. AC Q9BDT0; DT 21-NOV-2003, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-2001, sequence version 1. DT 27-MAR-2024, entry version 123. DE RecName: Full=Lysosomal acid glucosylceramidase {ECO:0000305}; DE EC=3.2.1.45 {ECO:0000250|UniProtKB:P04062}; DE AltName: Full=Acid beta-glucosidase; DE AltName: Full=Beta-glucocerebrosidase; DE AltName: Full=Cholesterol glucosyltransferase {ECO:0000250|UniProtKB:P04062}; DE Short=SGTase {ECO:0000250|UniProtKB:P04062}; DE EC=2.4.1.- {ECO:0000250|UniProtKB:P04062}; DE AltName: Full=Cholesteryl-beta-glucosidase {ECO:0000250|UniProtKB:P04062}; DE EC=3.2.1.- {ECO:0000250|UniProtKB:P04062}; DE AltName: Full=D-glucosyl-N-acylsphingosine glucohydrolase; DE AltName: Full=Lysosomal cholesterol glycosyltransferase {ECO:0000305}; DE AltName: Full=Lysosomal galactosylceramidase {ECO:0000305}; DE EC=3.2.1.46 {ECO:0000250|UniProtKB:P04062}; DE AltName: Full=Lysosomal glycosylceramidase {ECO:0000305}; DE Flags: Precursor; GN Name=GBA1; Synonyms=GBA {ECO:0000250|UniProtKB:P04062}, GC; OS Pan troglodytes (Chimpanzee). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Pan. OX NCBI_TaxID=9598; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RA Martinez-Arias R., Comas D., Bertranpetit J.; RT "Allelic variability on the glucocerebrosidase pseudogene."; RL Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Glucosylceramidase that catalyzes, within the lysosomal CC compartment, the hydrolysis of glucosylceramides/GlcCers (such as beta- CC D-glucosyl-(1<->1')-N-acylsphing-4-enine) into free ceramides (such as CC N-acylsphing-4-enine) and glucose. Plays a central role in the CC degradation of complex lipids and the turnover of cellular membranes. CC Through the production of ceramides, participates in the PKC-activated CC salvage pathway of ceramide formation. Catalyzes the glucosylation of CC cholesterol, through a transglucosylation reaction where glucose is CC transferred from GlcCer to cholesterol. GlcCer containing mono- CC unsaturated fatty acids (such as beta-D-glucosyl-N-(9Z-octadecenoyl)- CC sphing-4-enine) are preferred as glucose donors for cholesterol CC glucosylation when compared with GlcCer containing same chain length of CC saturated fatty acids (such as beta-D-glucosyl-N-octadecanoyl-sphing-4- CC enine). Under specific conditions, may alternatively catalyze the CC reverse reaction, transferring glucose from cholesteryl 3-beta-D- CC glucoside to ceramide. Can also hydrolyze cholesteryl 3-beta-D- CC glucoside producing glucose and cholesterol. Catalyzes the hydrolysis CC of galactosylceramides/GalCers (such as beta-D-galactosyl-(1<->1')-N- CC acylsphing-4-enine), as well as the transfer of galactose between CC GalCers and cholesterol in vitro, but with lower activity than with CC GlcCers. Contrary to GlcCer and GalCer, xylosylceramide/XylCer (such as CC beta-D-xyosyl-(1<->1')-N-acylsphing-4-enine) is not a good substrate CC for hydrolysis, however it is a good xylose donor for transxylosylation CC activity to form cholesteryl 3-beta-D-xyloside. CC {ECO:0000250|UniProtKB:P04062}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine + H2O = an N- CC acylsphing-4-enine + D-glucose; Xref=Rhea:RHEA:13269, CC ChEBI:CHEBI:4167, ChEBI:CHEBI:15377, ChEBI:CHEBI:22801, CC ChEBI:CHEBI:52639; EC=3.2.1.45; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:13270; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a beta-D-galactosyl-(1<->1')-N-acylsphing-4-enine + H2O = an CC N-acylsphing-4-enine + D-galactose; Xref=Rhea:RHEA:14297, CC ChEBI:CHEBI:4139, ChEBI:CHEBI:15377, ChEBI:CHEBI:18390, CC ChEBI:CHEBI:52639; EC=3.2.1.46; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14298; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC -!- CATALYTIC ACTIVITY: CC Reaction=cholesteryl 3-beta-D-glucoside + H2O = cholesterol + D- CC glucose; Xref=Rhea:RHEA:11956, ChEBI:CHEBI:4167, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:16113, ChEBI:CHEBI:17495; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:11957; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine + cholesterol CC = an N-acylsphing-4-enine + cholesteryl 3-beta-D-glucoside; CC Xref=Rhea:RHEA:58264, ChEBI:CHEBI:16113, ChEBI:CHEBI:17495, CC ChEBI:CHEBI:22801, ChEBI:CHEBI:52639; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58265; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:58266; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC -!- CATALYTIC ACTIVITY: CC Reaction=beta-D-glucosyl-N-(9Z-octadecenoyl)-sphing-4E-enine + CC cholesterol = cholesteryl 3-beta-D-glucoside + N-(9Z-octadecenoyl)- CC sphing-4-enine; Xref=Rhea:RHEA:58324, ChEBI:CHEBI:16113, CC ChEBI:CHEBI:17495, ChEBI:CHEBI:77996, ChEBI:CHEBI:139140; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58325; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:58326; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC -!- CATALYTIC ACTIVITY: CC Reaction=beta-D-glucosyl-N-octanoylsphing-4E-enine + cholesterol = CC cholesteryl 3-beta-D-glucoside + N-octanoylsphing-4-enine; CC Xref=Rhea:RHEA:70303, ChEBI:CHEBI:16113, ChEBI:CHEBI:17495, CC ChEBI:CHEBI:45815, ChEBI:CHEBI:65222; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70304; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:70305; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC -!- CATALYTIC ACTIVITY: CC Reaction=beta-D-glucosyl-N-dodecanoylsphing-4-enine + cholesterol = CC cholesteryl 3-beta-D-glucoside + N-dodecanoylsphing-4-enine; CC Xref=Rhea:RHEA:70307, ChEBI:CHEBI:16113, ChEBI:CHEBI:17495, CC ChEBI:CHEBI:72956, ChEBI:CHEBI:76297; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70308; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:70309; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC -!- CATALYTIC ACTIVITY: CC Reaction=beta-D-glucosyl-(1<->1)-N-octadecanoylsphing-4-enine + CC cholesterol = cholesteryl 3-beta-D-glucoside + N-octadecanoylsphing- CC 4-enine; Xref=Rhea:RHEA:70311, ChEBI:CHEBI:16113, ChEBI:CHEBI:17495, CC ChEBI:CHEBI:72961, ChEBI:CHEBI:84719; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70312; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:70313; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC -!- CATALYTIC ACTIVITY: CC Reaction=beta-D-glucosyl-(1<->1')-N-(15Z-tetracosenoyl)-sphing-4-enine CC + cholesterol = cholesteryl 3-beta-D-glucoside + N-(15Z- CC tetracosenoyl)-sphing-4-enine; Xref=Rhea:RHEA:70315, CC ChEBI:CHEBI:16113, ChEBI:CHEBI:17495, ChEBI:CHEBI:74450, CC ChEBI:CHEBI:76302; Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70316; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:70317; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a beta-D-galactosyl-(1<->1')-N-acylsphing-4-enine + CC cholesterol = an N-acylsphing-4-enine + cholesteryl 3-beta-D- CC galactoside; Xref=Rhea:RHEA:70235, ChEBI:CHEBI:16113, CC ChEBI:CHEBI:18390, ChEBI:CHEBI:52639, ChEBI:CHEBI:189066; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70236; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:70237; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-(beta-D-galactosyl)-N-dodecanoylsphing-4-enine + cholesterol CC = cholesteryl 3-beta-D-galactoside + N-dodecanoylsphing-4-enine; CC Xref=Rhea:RHEA:70255, ChEBI:CHEBI:16113, ChEBI:CHEBI:72956, CC ChEBI:CHEBI:73432, ChEBI:CHEBI:189066; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70256; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:70257; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a beta-D-xylosyl-(1<->1')-N-acylsphing-4-enine + cholesterol = CC an N-acylsphing-4-enine + cholesteryl 3-beta-D-xyloside; CC Xref=Rhea:RHEA:70239, ChEBI:CHEBI:16113, ChEBI:CHEBI:52639, CC ChEBI:CHEBI:189067, ChEBI:CHEBI:189068; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70240; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC -!- CATALYTIC ACTIVITY: CC Reaction=beta-D-xylosyl-(1<->1')-N-(9Z-octadecenoyl)-sphing-4-enine + CC cholesterol = cholesteryl 3-beta-D-xyloside + N-(9Z-octadecenoyl)- CC sphing-4-enine; Xref=Rhea:RHEA:70251, ChEBI:CHEBI:16113, CC ChEBI:CHEBI:77996, ChEBI:CHEBI:189067, ChEBI:CHEBI:189081; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70252; CC Evidence={ECO:0000250|UniProtKB:P04062}; CC -!- PATHWAY: Steroid metabolism; cholesterol metabolism. CC {ECO:0000250|UniProtKB:P04062}. CC -!- PATHWAY: Sphingolipid metabolism. {ECO:0000250|UniProtKB:P04062}. CC -!- SUBUNIT: Interacts with saposin-C. Interacts with SCARB2. Interacts CC with TCP1. Interacts with GRN; this interaction prevents aggregation of CC GBA1-SCARB2 complex via interaction with HSPA1A upon stress (By CC similarity). {ECO:0000250|UniProtKB:P04062}. CC -!- SUBCELLULAR LOCATION: Lysosome membrane {ECO:0000250|UniProtKB:P04062}; CC Peripheral membrane protein {ECO:0000250|UniProtKB:P04062}; Lumenal CC side {ECO:0000250|UniProtKB:P04062}. Note=Interaction with saposin-C CC promotes membrane association. Targeting to lysosomes occurs through an CC alternative MPR-independent mechanism via SCARB2. CC {ECO:0000250|UniProtKB:P04062}. CC -!- SIMILARITY: Belongs to the glycosyl hydrolase 30 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF285236; AAK18162.1; -; Genomic_DNA. DR RefSeq; NP_001008997.1; NM_001008997.1. DR RefSeq; XP_016804027.1; XM_016948538.1. DR RefSeq; XP_016804063.1; XM_016948574.1. DR AlphaFoldDB; Q9BDT0; -. DR SMR; Q9BDT0; -. DR STRING; 9598.ENSPTRP00000051730; -. DR CAZy; GH30; Glycoside Hydrolase Family 30. DR GlyCosmos; Q9BDT0; 5 sites, No reported glycans. DR PaxDb; 9598-ENSPTRP00000051730; -. DR Ensembl; ENSPTRT00000002601.6; ENSPTRP00000051730.4; ENSPTRG00000001416.5. DR GeneID; 449571; -. DR KEGG; ptr:449571; -. DR CTD; 2629; -. DR VGNC; VGNC:58837; GBA1. DR eggNOG; KOG2566; Eukaryota. DR GeneTree; ENSGT00390000009464; -. DR InParanoid; Q9BDT0; -. DR OMA; FGGIAWH; -. DR OrthoDB; 3473901at2759; -. DR UniPathway; UPA00296; -. DR Proteomes; UP000002277; Chromosome 1. DR Bgee; ENSPTRG00000001416; Expressed in dorsolateral prefrontal cortex and 21 other cell types or tissues. DR GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB. DR GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB. DR GO; GO:0005765; C:lysosomal membrane; ISS:UniProtKB. DR GO; GO:0005764; C:lysosome; ISS:UniProtKB. DR GO; GO:0005802; C:trans-Golgi network; ISS:UniProtKB. DR GO; GO:0004336; F:galactosylceramidase activity; IEA:RHEA. DR GO; GO:0004348; F:glucosylceramidase activity; ISS:UniProtKB. DR GO; GO:0046527; F:glucosyltransferase activity; ISS:UniProtKB. DR GO; GO:0005124; F:scavenger receptor binding; IEA:Ensembl. DR GO; GO:0050295; F:steryl-beta-glucosidase activity; ISS:UniProtKB. DR GO; GO:0006914; P:autophagy; ISS:UniProtKB. DR GO; GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl. DR GO; GO:0046513; P:ceramide biosynthetic process; IEA:Ensembl. DR GO; GO:0008203; P:cholesterol metabolic process; ISS:UniProtKB. DR GO; GO:0006680; P:glucosylceramide catabolic process; ISS:UniProtKB. DR GO; GO:0030259; P:lipid glycosylation; ISS:UniProtKB. DR GO; GO:0007040; P:lysosome organization; ISS:UniProtKB. DR GO; GO:0032715; P:negative regulation of interleukin-6 production; IEA:Ensembl. DR GO; GO:0031333; P:negative regulation of protein-containing complex assembly; IEA:Ensembl. DR GO; GO:1904457; P:positive regulation of neuronal action potential; IEA:Ensembl. DR GO; GO:0035307; P:positive regulation of protein dephosphorylation; IEA:Ensembl. DR GO; GO:1903061; P:positive regulation of protein lipidation; IEA:Ensembl. DR GO; GO:0043243; P:positive regulation of protein-containing complex disassembly; IEA:Ensembl. DR GO; GO:0032006; P:regulation of TOR signaling; ISS:UniProtKB. DR GO; GO:0046512; P:sphingosine biosynthetic process; IEA:Ensembl. DR GO; GO:0023021; P:termination of signal transduction; IEA:Ensembl. DR Gene3D; 3.20.20.80; Glycosidases; 1. DR InterPro; IPR033452; GH30_C. DR InterPro; IPR001139; Glyco_hydro_30. DR InterPro; IPR033453; Glyco_hydro_30_TIM-barrel. DR InterPro; IPR017853; Glycoside_hydrolase_SF. DR PANTHER; PTHR11069; GLUCOSYLCERAMIDASE; 1. DR PANTHER; PTHR11069:SF33; LYSOSOMAL ACID GLUCOSYLCERAMIDASE; 1. DR Pfam; PF02055; Glyco_hydro_30; 1. DR Pfam; PF17189; Glyco_hydro_30C; 1. DR PRINTS; PR00843; GLHYDRLASE30. DR SUPFAM; SSF51445; (Trans)glycosidases; 1. DR SUPFAM; SSF51011; Glycosyl hydrolase domain; 2. PE 3: Inferred from homology; KW Cholesterol metabolism; Disulfide bond; Glycoprotein; Glycosidase; KW Glycosyltransferase; Hydrolase; Lipid metabolism; Lysosome; Membrane; KW Reference proteome; Signal; Sphingolipid metabolism; Steroid metabolism; KW Sterol metabolism; Transferase. FT SIGNAL 1..39 FT /evidence="ECO:0000250" FT CHAIN 40..536 FT /note="Lysosomal acid glucosylceramidase" FT /id="PRO_0000012179" FT ACT_SITE 274 FT /note="Proton donor" FT /evidence="ECO:0000250" FT ACT_SITE 379 FT /note="Nucleophile" FT /evidence="ECO:0000250" FT CARBOHYD 58 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 98 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 185 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 309 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 501 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 43..55 FT /evidence="ECO:0000250|UniProtKB:P04062" FT DISULFID 57..62 FT /evidence="ECO:0000250|UniProtKB:P04062" SQ SEQUENCE 536 AA; 59664 MW; E1A61BF380FF1888 CRC64; MEFSSPSREE CPKPSGRVSI MAGSLTGLLL LQAVSWASGA RPCIPKSFGY SSVVCVCNAT YCDSFDPPTF PALGTFSRYE STRSGRRMEL SMGTIQANHT GTGLLLTLQP EQKFQKVKGF GGAMTDAAAL NILALSPPAQ NLLLKSYFSE EGIGYNIIRV PMASCDFSIR TYTYADTPDD FQLHNFSLPE EDTKLKIPLI HRALQLAQRP VSLLASPWTS PTWLKTNGAV NGKGSLKGQP GDIYHQTWAR YFVKFLDAYA EHKLQFWAVT AENEPSAGLL SGYPFQCLGF TPEHQRDFIA RDLGPTLANS THHNVRLLML DDQRLLLPHW AKVVLTDPEA AKYVHGIAVH WYLDFLAPAK ATLGETHRLF PNTMLFASEA CVGSKFWEQS VRLGSWDRGM QYSHSIITNL LYHVVGWTDW NLALNPEGGP NWVRNFVDSP IIVDITKDTF YKQPMFYHLG HFSKFIPEGS QRVGLVASQK NDLDAVALMH PDGSAVVVVL NRSSKDVPLT IKDPAVGFLE TISPGYSIHT YLWRRQ //